deltatrials
Unknown OBSERVATIONAL NCT05247710

Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis

Sponsor: Olfactomics Oy

Conditions Basal Cell Carcinoma
Interventions Punch biopsy
Updated 5 times since 2022 Last updated: Jul 4, 2023 Started: Dec 9, 2022 Primary completion: Dec 31, 2023 Completion: Jun 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05247710, this observational or N/A phase trial focuses on Basal Cell Carcinoma and remains ongoing. Sponsored by Olfactomics Oy, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Mar 2022 – ~Aug 2023 · 17 months · monthly snapshotNot Yet Recruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – present · 16 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. May 2025 — Present [monthly]

    Unknown

    Status: Recruiting → Unknown

  2. Sep 2024 — May 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Aug 2023 — Jul 2024 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  5. Mar 2022 — Aug 2023 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Olfactomics Oy
  • Tampere University Hospital
Data source: Tampere University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations